Director/PDMR Shareholding

RNS Number : 5034O

Helios Underwriting Plc

01 June 2020

 

Helios Underwriting plc

("Helios" or the "Company")

Directors' Dealing

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's , was notified on 29 May 2020 that Michael Cunningham, Non-Executive Chairman of the Company, ha d   on the same day purchased 22,000 ordinary shares of 10 pence each in the Company ('Ordinary Shares') at a price of 88.5 pence per share.  As a result, Mr . Cunningham   has a total beneficial interest of 78,698 Ordinary Shares, representing 0. 44 per cent. of the Company's issued share capital.

In addition, the Company was notified on 29 May 2020 that Andrew Christie, Non-Executive Director of the Company, had on the same day purchased 11,117   O rdinary S hares at a price of 90 pence per share.  As a result, Mr .   Christie has a total beneficial interest of 31,096 Ordinary Shares, representing 0.17 per cent. of the Company's issued share capital.

For further information please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive                                                  07787  530404 /  [e-mail]

Arthur Manners - Chief Financial Officer                                    07754 965 917

Shore Capital

Robert Finlay/David Coaten                                                           020 7408 4090

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £70m of capacity for the 2020 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

END

 

 

DSHQFLBBBQLLBBD